Prof Marc Bonten announces clinical experiments in UMC Utrecht with bacteriophage therapy
22 November 2017
In a radio interview on 21st of November, Prof Marc Bonten, medical microbiologist, announced that the University Medical Centre in Utrecht (UMCU) is planning experimental treatments with bacteriophage therapy in lung infections. Prof Bonten expects the first experimental treatments with bacteriophage therapy to start in the first quarter of 2018, under the condition that the Medical Ethics Review Committee agrees with the investigation. Prof Marc Bonten is board member of the NADP.
The news item (in Dutch) on NPO Radio 1 (Nieuws & co) can be listened here: